Correlations of programmed death 1 expression and serum IL-6 level with exhaustion of cytomegalovirus-specific T cells after allogeneic hematopoietic stem cell transplantation-Reference-Cited by-同舟云学术

Correlations of programmed death 1 expression and serum IL-6 level with exhaustion of cytomegalovirus-specific T cells after allogeneic hematopoietic stem cell transplantation

Published:2014-03 Issue:1-2 Volume:288 Page:53-59
ISSN:0008-8749
Container-title:Cellular Immunology
language:en
Short-container-title:Cellular Immunology

Author:

Kato Tomonori,Nishida Tetsuya,Ito Yoshinori,Murase Miho,Murata Makoto,Naoe Tomoki

Publisher

Elsevier BV

Subject

Immunology

Reference40 articles.

1. Late cytomegalovirus disease and mortality in recipients of allogeneic hematopoietic stem cell transplants: importance of viral load and T-cell immunity;Boeckh;Blood,2003

2. How we treat cytomegalovirus in hematopoietic cell transplant recipients;Boeckh;Blood,2009

3. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor;Walter;N. Engl. J. Med.,1995

4. Adoptive cellular therapy for early cytomegalovirus infection after allogeneic stem-cell transplantation with virus-specific T-cell lines;Peggs;Lancet,2003

5. Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy;Einsele;Blood,2002

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating cytokine and chemokine patterns associated with cytomegalovirus reactivation after stem cell transplantation;Clinical & Translational Immunology;2023-01

2. Extended-duration letermovir prophylaxis for cytomegalovirus infection after cord blood transplantation in adults;Blood Advances;2022-12-27

3. Risk prediction of CMV reactivation after allogeneic stem cell transplantation using five non-HLA immunogenetic polymorphisms;Annals of Hematology;2022-05-07

4. Cytokine Release Syndrome during Antithymocyte Globulin/Anti-T Lymphocyte Globulin Serotherapy for Graft-versus-Host Disease Prophylaxis before Allogeneic Hematopoietic Stem Cell Transplantation: Incidence and Early Clinical Impact According to American Society of Transplantation and Cellular Therapy Grading Criteria;Transplantation and Cellular Therapy;2022-05

5. mTOR Inhibitors Prevent CMV Infection through the Restoration of Functional αβ and γδ T cells in Kidney Transplantation;Journal of the American Society of Nephrology;2021-11-01